---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-020323"
form_type: "8-K"
ticker: "BACK"
cik: "0001729944"
company_name: "IMAC Holdings, Inc."
filed_at: "2024-05-16T23:59:59+00:00"
generated_at: "2026-06-01T21:32:09.995052+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# IMAC Holdings enters $450K PIPE financing and acquires Theralink assets in settlement

## Summary
- On May 13, 2024, IMAC sold 450 shares of Series F convertible preferred stock and warrants for $450,000 cash.
- Series F preferred has 10% annual dividend, converts at $3.401/share, and is redeemable at 110% of stated value.
- Company acquired all assets of Theralink Technologies in settlement, forgiving $3M in notes and issuing Series D and E preferred.
- IMAC will seek stockholder approval for issuance of shares under Nasdaq rules for the Series F and warrants.
- Warrants have $3.401 exercise price, become exercisable after six months, and expire five years later.

## SEC filing metadata
- accession: 0001493152-24-020323
- form_type: 8-K
- ticker: BACK
- cik: 0001729944
- company_name: IMAC Holdings, Inc.
- filed_at: 2024-05-16T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729944/000149315224020323/0001493152-24-020323-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729944/000149315224020323/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-020323
- JSON: https://secwatch.observer/filing/0001493152-24-020323.json
- Plain text: https://secwatch.observer/filing/0001493152-24-020323.txt

## Key facts
- Material Agreements
  IMAC Holdings, Inc. entered into Securities Purchase Agreement with accredited investors valued at $450,000 (effective 2024-05-13).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: accredited investors
  - Value: $450,000
  - Effective: 2024-05-13
  source text: On May 13, 2024, IMAC Holdings, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell, and the Investors agreed to purchase, 450 shares of Series F convertible preferred stock, par value $0.001 per share (“Series F Preferred Stock”) and warrants (the “Warrants”, and, together with the Series F Preferred Stock, the “Securities”), for aggregate cash proceeds of $450,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1729944/000149315224020323/0001493152-24-020323-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.